Literature DB >> 29588790

Transcatheter Aortic Valve Replacement and Left Atrial Appendage Occlusion - A Stitch in Time?

Sameer Gafoor1, Luisa Heuer1, Jennifer Franke1,2, Stefan Bertog1,3, Laura Vaskelyte1, Ilona Hofmann1, Horst Sievert1.   

Abstract

Many patients have now been able to receive transcatheter aortic valve replacement (TAVR) therapy for severe aortic stenosis. These patients have atrial fibrillation and are placed on warfarin for stroke prophylaxis. The opportunity for treatment with left atrial appendage occlusion (LAAO) in place of warfarin for this population exists, especially for those with increased bleeding risk. This paper discusses the prevalence and aetiology of stroke in patients presenting for TAVR (with a focus on the risk from chronic and acute atrial fibrillation) and also the benefit of LAAO closure in this population.

Entities:  

Keywords:  Aortic stenosis; aortic valve replacement; atrial fibrillation; left atrial appendage; left atrial appendage closure; left atrial appendage occlusion; transcatheter aortic valve implantation; transcatheter aortic valve replacement

Year:  2014        PMID： 29588790      PMCID： PMC5808492          DOI： 10.15420/icr.2011.9.2.126

Source DB:  PubMed          Journal:  Interv Cardiol        ISSN： 1756-1485


  42 in total

1.  Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies.

Authors:  Philippe Généreux; Stuart J Head; Nicolas M Van Mieghem; Susheel Kodali; Ajay J Kirtane; Ke Xu; Craig Smith; Patrick W Serruys; A Pieter Kappetein; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2012-04-11       Impact factor: 24.094

2.  Left ventricular guidewire pacing for transcatheter aortic valve implantation.

Authors:  Enio E Guérios; Peter Wenaweser; Bernhard Meier
Journal:  Catheter Cardiovasc Interv       Date:  2013-03-08       Impact factor: 2.692

3.  Catch me if you can.

Authors:  Adrian Attinger-Toller; Thomas F Lüscher; Ulf Landmesser; Fabian Nietlispach
Journal:  Eur Heart J       Date:  2013-11-24       Impact factor: 29.983

4.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

5.  Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status.

Authors:  Timothy A Fairbairn; Adam N Mather; Petra Bijsterveld; Gillian Worthy; Stuart Currie; Anthony J P Goddard; Daniel J Blackman; Sven Plein; John P Greenwood
Journal:  Heart       Date:  2011-07-07       Impact factor: 5.994

6.  Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage.

Authors:  Solveig Horstmann; Christian Zugck; Ulrike Krumsdorf; Timolaos Rizos; Geraldine Rauch; Nicolas Geis; Stefan Hardt; Roland Veltkamp
Journal:  Neurology       Date:  2013-12-06       Impact factor: 9.910

7.  Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors:  Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal:  Circulation       Date:  2011-01-17       Impact factor: 29.690

8.  Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.

Authors:  Jens Wiebe; Stefan Bertog; Jennifer Franke; Olga Wettstein; Katharina Lehn; Ilona Hofmann; Laura Vaskelyte; Horst Sievert
Journal:  Catheter Cardiovasc Interv       Date:  2014-01-08       Impact factor: 2.692

9.  Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.

Authors:  Oluseun Alli; Shepal Doshi; Saibal Kar; Vivek Reddy; Horst Sievert; Chris Mullin; Vijay Swarup; Brian Whisenant; David Holmes
Journal:  J Am Coll Cardiol       Date:  2013-02-28       Impact factor: 24.094

10.  Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.

Authors:  Sheldon M Singh; Andrew Micieli; Harindra C Wijeysundera
Journal:  Circulation       Date:  2013-05-22       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.